Anders Själander Selected Research

Anders Själander Research Topics

Disease

21	Atrial Fibrillation 09/2023 - 09/2011
21	Hemorrhage 07/2023 - 06/2007
15	Stroke (Strokes) 07/2023 - 05/2014
6	Ischemic Stroke 05/2023 - 05/2014
6	Venous Thromboembolism 01/2021 - 09/2011
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 09/2011
3	Myocardial Infarction 01/2022 - 01/2016
3	Thrombosis (Thrombus) 01/2021 - 05/2014
3	Embolism (Embolus) 01/2018 - 01/2017
3	Thromboembolism 11/2016 - 06/2015
2	Atherosclerosis 02/2024 - 01/2022
2	Anemia 09/2023 - 01/2018
2	Heart Failure 01/2022 - 11/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2024
1	Essential Thrombocythemia 06/2023
1	Polycythemia Vera 06/2023
1	Chronic Renal Insufficiency 05/2023
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Hypoalbuminemia 01/2021
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021
1	Inflammation (Inflammations) 01/2020
1	Gastritis 01/2020
1	Ulcer 01/2020
1	Dyspepsia (Indigestion) 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Peptic Ulcer (Peptic Ulcers) 01/2020
1	Transient Ischemic Attack 11/2017
1	Hypertension (High Blood Pressure) 11/2017
1	Heart Diseases (Heart Disease) 11/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 02/2016
1	Renal Insufficiency (Renal Failure) 01/2016
1	Neoplasms (Cancer) 06/2015
1	Second Primary Neoplasms (Neoplasms, Second) 06/2015
1	Musculoskeletal Pain 09/2014
1	Hematuria 08/2007
1	Epistaxis (Nosebleed) 08/2007

Drug/Important Bio-Agent (IBA)

23	Warfarin (Coumadin)FDA LinkGeneric 05/2023 - 06/2007
12	AnticoagulantsIBA 09/2023 - 05/2014
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 09/2014
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 05/2014
4	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 09/2011
3	Dabigatran FDA Link 07/2023 - 01/2017
3	apixabanIBA 07/2023 - 01/2017
3	RivaroxabanIBA 07/2023 - 01/2017
2	Dasatinib (BMS 354825)FDA Link 01/2022 - 01/2016
2	nilotinib FDA Link 01/2022 - 01/2016
2	insulin receptor-related receptor (IRR)IBA 01/2022 - 01/2021
2	N(4)-oleylcytosine arabinosideIBA 01/2018 - 01/2017
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2017 - 12/2012
2	Vitamin K FDA Link 01/2017 - 01/2016
1	Blood Group Antigens (Blood Groups)IBA 02/2024
1	ABO Blood-Group SystemIBA 02/2024
1	Hemoglobins (Hemoglobin)IBA 06/2023
1	LipidsIBA 01/2022
1	AlbuminsIBA 01/2021
1	Proton Pump InhibitorsIBA 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	Clopidogrel (Plavix)FDA Link 01/2018
1	edoxabanIBA 01/2017
1	Prothrombin (Factor II)IBA 09/2009

Therapy/Procedure

4	Therapeutics 01/2018 - 01/2016
3	Heart Valve Prosthesis 11/2017 - 05/2014
1	Contraindications 09/2023
1	Percutaneous Coronary Intervention 01/2018
1	Catheter Ablation 01/2017
1	Prostheses and Implants (Prosthesis) 11/2016
1	Secondary Prevention 12/2015
1	Tooth Extraction (Tooth Extractions) 08/2007